Open Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Open Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery
Authors
Keywords
Drug discovery, Open access publishing, Phase I clinical investigation, Leukemias, Drug research and development, Acute myeloid leukemia, Lymphomas, Drug therapy
Journal
PLOS BIOLOGY
Volume 13, Issue 6, Pages e1002164
Publisher
Public Library of Science (PLoS)
Online
2015-06-05
DOI
10.1371/journal.pbio.1002164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical target validation using patient-derived cells
- (2015) Aled M. Edwards et al. NATURE REVIEWS DRUG DISCOVERY
- Human UTY(KDM6C) Is a Male-specificNϵ-Methyl Lysyl Demethylase
- (2014) Louise J. Walport et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Patent-free pact pushes the boundaries of precompetitive research
- (2014) Elie Dolgin NATURE MEDICINE
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor
- (2013) Agustin H. Mohedas et al. ACS Chemical Biology
- PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
- (2013) S. Picaud et al. CANCER RESEARCH
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
- (2013) Priti Anand et al. CELL
- BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
- (2013) Jessica I. Spiltoir et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Open source drug discovery – A limited tutorial
- (2013) MURRAY N. ROBERTSON et al. PARASITOLOGY
- A New Class of Small Molecule Inhibitor of BMP Signaling
- (2013) Caroline E. Sanvitale et al. PLoS One
- Bromodomain Proteins in HIV Infection
- (2013) Daniela Boehm et al. Viruses-Basel
- Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
- (2012) Guillermo Senisterra et al. BIOCHEMICAL JOURNAL
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva
- (2012) Apirat Chaikuad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
- (2012) Laurens Kruidenier et al. NATURE
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- An Allosteric Inhibitor of Protein Arginine Methyltransferase 3
- (2012) Alena Siarheyeva et al. STRUCTURE
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- (2012) Wenyu Yu et al. Nature Communications
- Short Hairpin RNA Screen Reveals Bromodomain Proteins as Novel Targets in Acute Myeloid Leukemia
- (2011) Gerd A. Blobel et al. CANCER CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family
- (2011) Lars Hillringhaus et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Too many roads not taken
- (2011) Aled M. Edwards et al. NATURE
- Getting pharmaceutical R&D back on target
- (2011) Mark E Bunnage Nature Chemical Biology
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reader's block
- (2010) Sean D. Taverna et al. NATURE
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Structural Biology of Human H3K9 Methyltransferases
- (2010) Hong Wu et al. PLoS One
- Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors
- (2010) Oliver N. F. King et al. PLoS One
- Open access chemical and clinical probes to support drug discovery
- (2009) Aled M Edwards et al. Nature Chemical Biology
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases⊥
- (2008) Nathan R. Rose et al. JOURNAL OF MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started